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Abstract An N-sulfanylethylanilide (SEAlide)-based ligation was developed for 
the preparation of trichamide, a thiazole-containing cyclic peptide isolated 
from bloom-forming cyanobacterium Trichodesmium erythraeum. In this 
cysteine-free ligation, 4-mercaptobenzylphosphonic acid (MBPA) functions 
as a dual promoter both for the N–S acyl-transfer-mediated activation of the 
SEAlide unit and for subsequent ligation. Furthermore, we established a high-
yielding route to enantiomerically pure thiazole amino acids using a one-pot 
Hantzsch process. 
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A wide variety of cyclic peptides and depsipeptides have been 
discovered from natural sources, constituting a potential 
chemical space for drug seeds or leads.1 Additionally, by aiding 
in the arrangement of pharmacophore residues, structural 
simulation has provided a rational approach to develop cyclic 
peptide-based drugs.2 Because of the importance of cyclization, 
much effort has focused on developing methods for the 
formation of the indispensable lactam or lactone linkage.3 
Among a vast number of cyclization protocols, the use of 
thioester unit is receiving increasing attention due to its 
chemoselective reactivity.4 For example, native chemical 
ligation (NCL) is the reaction of a thioester with an N-terminal 
cysteine residue in aqueous solution.5 While widely used, 
standard NCL offers a limited ligation site (Xaa–Cys: Xaa = amino 
acid) without using desulfurization of unnatural amino acids 
bearing mercapto group for the synthesis of cyclic peptides.6,7 A 
cysteine-free ligation was developed using acidic amino acids 
such as aspartic or glutamic acid in aqueous N-
methylpyrrolidone (NMP), where the carboxylate anion 
intramolecularly interacts with the amine unit facilitating direct 
aminolysis with thioesters.8 The requirement of NMP for 
cysteine-free ligation is attributable to the suppression of 
thioester hydrolysis during an aminolysis that is slow in 
comparison to NCL. 
 We have developed an alternative approach to cysteine-free 
ligation using N-sulfanylethylanilide (SEAlide) peptide 1 as a 
crypto-thioester, with successful application to protein chemical 
synthesis using a one-pot/N–to–C-directive sequential NCL 
protocol.9 In the presence of phosphate salts, the SEAlide 
peptide likely undergoes NCL through N–S acyl-transfer-
mediated formation of thioester 2 to afford ligated material, 
whereas the amide-type SEAlide remains largely intact in the 
absence of phosphate salts. 
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Scheme 1 Synthetic Strategy of Trichamide Using SEAlide Peptide 
 
Recently, trichamide (3) possessing thiazole amino acids was 
isolated from the globally-occurring, bloom-forming 
cyanobacterium, Trichodesmium erythraeum.10 The biological 
significance of 3 has yet to be elucidated, despite its potential 
presence in high amounts in oceanic blooms. Moreover, 3 was 
identified by genome mining and mass spectrometry, and its 
small quantity in culture made further structural evidence 
highly challenging. This naturally occurring cyclic peptide has 
Gly–Asp sequence in the molecule, which could probably be 
constructed by the cysteine-free ligation mentioned above. 
Although we did not know whether an acidic residue was 
required at the N-terminus, this provided a conservative 
starting point for assessing the potential of our method. In this 
context, we here examined the applicability of the SEAlide 
peptide to the cysteine-free ligation for the preparation of 
trichamide (Scheme 1).   
First, we synthesized model SEAlide peptide 4 by Fmoc solid-
phase peptide synthesis (SPPS) to examine the feasibility of a 
SEAlide-mediated cysteine-free ligation for the construction of 
the cyclic structure. The cysteine-free ligation was conducted in 
NMP/H2O (4/1 (v/v)) in the presence of 15 mM tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) as an inhibitor 
of oxidation of thiols at pH 7.6, 37 °C. The use of 4-
mercaptophenyl acetic acid (MPAA) for the cyclization of 4 
resulted in low conversion yield (Table 1, entry 1). Our previous 
investigation on the SEAlide-mediated NCL reaction in aqueous 
solution indicated that phosphate salts accelerate the NCL 
through facilitation of the N–S acyl transfer of the SEAlide unit.9 
Thus, we added phosphate salts (20 mM) in NMP/H2O to 
promote the cyclization. However, no significant improvement 
was observed (Table 1, entry 2). 
 One potential explanation for such results is that high 
concentration of phosphate salts cannot be used in the mixed 
solvent consisting of NMP/H2O (4/1 (v/v)) due to the sparingly 
soluble nature of the phosphate in NMP. Instead of phosphate 
salts, addition of benzylphosphonic acid in the presence of 
MPAA dramatically improved the conversion yield (Table 1, 
entry 3). Here, benzylphosphonic acid probably works as a more 
promising promoter for the N–S acyl transfer in the NMP/H2O 
system. Therefore, we next examined the usefulness of 4-
mercaptobenzylphosphonic acid (MBPA) bearing thiol and 
phosphonic acid units in the molecule.11 Further improvement 
of the conversion was observed, and desired cyclized product 5 
was obtained from the SEAlide precursors 4 in reasonable 
isolated yields  (Table 1, entry 4). Under employed reaction 
conditions (concentration of peptide: 5.0 x 10-4 M), some peaks 
derived from components of ligation buffer were observed by 
HPLC analysis; however, no oligomerized product was detected. 
 
 
Table 1 Intramolecular Ligation of SEAlide Peptide Using Various Additives  
 
entry additive conversiona (%) yieldb (%) 
1 MPAA 24  
2 MPAA, Na2HPO4 19  
3 MPAA, benzylphosphonic acid 79  
4 MBPA 82 65 
aConversion was determined by HPLC separation and peak areas (See Supporting 
Information.). bIsolated yield after HPLC purification. Reaction conditions: pep-
tides (0.5 mM), NMP/H2O (4/1 (v/v)) containing 20 mM additives and 15 mM 
TCEP·HCl, final pH 7.6, 37 °C, 72 h. During the cyclization of 4, aryl thioester 
intermediates were detected. 
 
Benzylphosphonic acid derivatives promote N–S acyl 
transfer-mediated activation of SEAlide in aqueous solution. To 
elucidate its role in NMP/H2O, we synthesized alkyl thioester 
peptide 6, which would not require N–S acyl transfer prior to 
cysteine-free ligation. Using the conditions listed in Table 1, 6 
was cyclized in nearly quantitative conversion yield (Scheme 2 
and see supporting information). These results indicate that 
benzylphosphonic acid derivatives promote N–S acyl transfer in 
both aqueous and NMP/H2O solvents.  
 
aConversion was determined by HPLC separation and peak areas (See Supporting 
Information.). 
Scheme 2 Intramolecular Ligation of Thioester Fragment with Various 
Additives 
 
Table 2 Intramolecular Ligation of SEAlide Peptide with Different N-/C-
Terminal Amino Acids 
 
entry peptide   Conversiona 
(%) 
  X Z  
1 7a Glu Gly 81 
2 7b Phe Gly 74 
3 7c Asp Ala 82 
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4 7d Gly Ala 86 
aConversion was determined by HPLC separation and peak areas (See Supporting 
Information.). Reaction conditions: peptides (0.5 mM), NMP/H2O (4/1 (v/v)) con-
taining 20 mM MBPA and 15 mM TCEP·HCl, final pH 7.6, 37 °C, 48 h. 
 
To confirm the general applicability of the SEAlide-mediated 
cysteine-free ligation to synthesis of cyclic peptides, non-acidic 
amino acids (Phe and Gly) as the amine component were 
subjected to the ligation protocol. Even at the non-acidic sites, 
cysteine-free ligation proceeded efficiently to yield cyclized 
materials (Table 2, entries 1 vs 2; entries 3 vs 4), although about 
10% epimerization was observed at Ala adjacent to the thioester 
(Table 2, entries 3 and 4) (see supporting information).  
Having established a synthetic platform using the SEAlide-based 
cysteine-free ligation for trichamide, we next turned our 
attention to the synthesis of two Fmoc-protected thiazole amino 
acids requisite for a preparation of trichamide (Schemes 3 and 
4). Amidation of commercially available Fmoc amino acids 9 and 
10 with ammonium hydrogen carbonate in the presence of 
(benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate (PyBOP®) and diisopropylethylamine 
(DIPEA) in DMF, followed by thioamidation with Lawesson’s 
reagent in CH2Cl2, afforded thioamides 11 and 12 in 84% and 
89% yields over two steps, respectively. 
 
 
Scheme 3 Synthesis of Thioamides 
 
Next, the resulting thioamides 11 and 12 were subjected to the 
Hantzsch thiazole synthesis in accordance with procedures 
described in the literature.12 Ethyl bromopyruvate was reacted 
with thioamides 11 and 12 in the presence of excess amount of 
KHCO3 at –40 °C. After being stirred at 0 °C for 12 h, the reaction 
mixture was filtered, and the filtrate was concentrated. The 
generated hydroxythiazolines 13 and 14 were dehydrated by 
the action of trifluoroacetic anhydride (TFAA) and 2,6-lutidine 
to give thiazole units 15 and 16 in 79% isolated yields, 
respectively (Table 3, entries 1 and 2). Chiral high-performance 
liquid chromatography (HPLC) analysis indicated that the 
synthesis of 15 starting from serine was accompanied by partial 
loss of optical purity (Table 3, entry 1). Since the serine 
derivative tends to epimerize during the synthetic process,13 
serine-derived thioamide 11 was subjected to experiments 
examining epimerization. Generally, the first step of 
conventional Hantzsch thiazole synthesis uses an excess amount 
of inorganic base such as KHCO3 (11 eq.) in 1,2-
dimethoxyethane (DME) for the formation of hydroxythiazoline 
followed by filtration and subsequent concentration of the 
solvent.12 Therefore, we investigated the use of organic bases. 
Reaction of 11 with ethyl bromopyruvate in the presence of 
DIPEA (3 eq.) in DME for 30 min at room temperature followed 
by direct addition of TFAA (2.5 eq.)/2,6-lutidine (3 eq.) into the 
reaction mixture with additional stirring for 30 min at 0 °C gave 
desired thiazole 15 in 8% isolated yield and 66% ee. 
Replacement of DIPEA with pyridine as a milder base allowed 
for the overall reaction to proceed smoothly, and the desired 15 
was obtained in 88% isolated yield and 88% ee (Table 3, entries 
3 and 4). Furthermore, the use of more hindered pyridine-type 
base (2,6-lutidine) in the first step enabled optically pure 15 
(>99% ee) to be obtained in high chemical yield (94%) (Table 3, 
entry 5). These optimized reaction conditions were successfully 
applied to the preparation of highly optically pure leucine-
derived thiazole 16 in highly chemical yield (Table 3, entry 6). 
Note that the optimized one-pot procedure for the Hantzsch 
thiazole synthesis is a practical and reliable method for the 
synthesis of enantiomerically pure thiazole derivatives from 
commercially available Fmoc-protected amino acids. During the 
course of our research, Yamaguchi and co-workers 
independently reported a similar one-pot procedure for 
preparation of thiazoles.14 
 
 
Scheme 4 Synthesis of Thiazole Building Blocks 
 
Table 3 Optimization of One-pot Hantzsch Thiazole Synthesis 
entry substrate base 
(Step 1) 
temp (°C)/t 
(h) 
 Yielda 
(%) 
eeb 
(%) 
   Step 1 Step 2   
1c 11 KHCO3 –40→0/12 –40/12 79 80 
2c 12 KHCO3 –40→0/12 –40/12 80 95 
3d 11 DIPEA rt/0.5 0/0.5 8 66 
4d 11 Pyridine rt/0.5 0/0.5 88 88 
5d 11 2,6-lutidine rt/0.5 0/0.5 93 >99 
6d 12 2,6-lutidine rt/0.5 0/0.5 98 >99 
Reaction conditions in step 1: KHCO3 (11 eq.), other bases (3 eq.). Reaction 
conditions in step 2: TFAA (entries 1 and 2: 9 eq., entries 3–6: 3 eq.), 2,6-lutidine 
(entries 1 and 2: 4 eq., entries 3–6: 3 eq.). aIsolated yield. bDetermined by chiral 
HPLC analysis.  cAfter a formation of 17 or 18, reaction mixture was filtered and 
evaporated. dReaction mixture was used for step 2 directly. 
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Scheme 5 Synthesis of Trichamide 
 
Finally, the resulting ethyl esters 15 and 16 were hydrolyzed by 
refluxing in 1,2-dichloroethane in the presence of Me3SnOH15 for 
8 h to yield the requisite Fmoc-protected thiazole amino acids 
17 and 18 in 94% and quantitative yields, respectively. With 
required intermediates in hand, Fmoc-based preparation of 
trichamide (3) was attempted (Scheme 5). On the Fmoc-glycyl-
N-sulfanylethylaniline linker-incorporated–Leu–NovaSyn® TGR 
resin, thiazole amino acids and other Fmoc amino acids were 
incorporated with the aid of N,N,N',N'-tetramethyl-O-(1H-
benzotriazol-1-yl) uronium hexafluorophosphate (HBTU)/ 
DIPEA and N,N'-diisopropylcarbodiimide (DIPCDI)/ 1-
hydroxybenzotriazole monohydrate (HOBt·H2O), respectively. 
After completion of the linear peptide synthesis, treatment of 
the resin with TFA/thioanisole/m-cresol/1,2-
ethanedithiol/H2O (80/5/5/5/5 (v/v)) for 2 h at room 
temperature followed by HPLC purification gave amide-type 
linear SEAlide peptide 19 in 34% isolated yield. Following the 
conditions obtained from model experiments, intramolecular 
ligation was achieved in NMP/H2O (4/1 (v/v)) in the presence 
of 20 mM MBPA and 15 mM TCEP at pH 7.6, 37 °C (concentration 
of peptide: 5.0 x 10-4 M).16 Reaction proceeded smoothly over 72 
h to yield desired trichamide 3 in 63% isolated yield after HPLC 
purification as shown in Figure 1. HPLC-monitoring of the 
SEAlide-based cysteine free ligation clearly indicated that 
amide-type linear SEAlide peptide 19 was gradually converted 
to trichamide (3) through linear MBPA thioester intermediate 
20 without side reactions. 
The structure of trichamide (3) was previously determined only 
by genomics and MS analysis. To provide definitive evidence for 
the structure of 3, we obtained extracts of T. erythraeum and 
compared them with the synthetic compound. Two strains were 
selected for analysis: ISM101, from which trichamide was 
previously identified, and GBR. Trichamide (3) was only 
produced by ISM101, and only at lower temperatures. The 
presence or absence of phosphate did not matter to trichamide 
production (see supporting information). When produced, the 
yield of trichamide was ~5–10 μg per liter of culture broth, as 
estimated by comparison with synthetic 3. Given the slow 
growth of the bacteria and the low abundance in culture, 
synthesis provides a practical means of structure elucidation. 
Using HPLC- and UPLC-MS, synthetic 3 co-eluted with 3 from T. 
erythraeum under all conditions attempted (see supporting 
information). To further verify that the natural and synthetic 
compounds were likely identical, we subjected the compounds 
to the same Fourier transform MS protocol used in the initial 
identification of 3. In comparing the resulting MS2 spectra, 
fragment ions were identical. Thus, the synthesis provides 
strong evidence supporting the proposed structure of the 
natural product. In addition, using the synthetic material NMR 
chemical shift data was provided for 3 for the first time. 
 
 
Figure 1 HPLC monitoring of the cysteine-free ligation for the synthesis of 
trichamide. HPLC conditions are described in the supporting information. 
 
In conclusion, we achieved the chemical synthesis of trichamide 
using a cysteine-free ligation. One key to the success was 
development of a SEAlide-based cysteine-free ligation that 
featured the use of MBPA as dual promoter for the N–S acyl 
transfer and subsequent ligation as phosphate salts and MPAA, 
respectively. Further examination of the applicability of this 
ligation at various amino acids in the C- or N-termini is still 
ongoing. Another key is improvement of synthetic protocols for 
enantiomerically pure Fmoc-protected thiazole amino acids 
where one-pot Hantzsch procedure was developed. 
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